Modeling prostate cancer distributions - incidence, histology and morphometric observations

By Frimmel H.   Egevad L.   Bengtsson E.   Busch C.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1028-1034

Elsevier

Access to resources Recommend Favorite

Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer

By Taylor J.A.   Gancarczyk K.J.   Fant G.V.   Mcleod D.G.  

Urology, Vol. 60, Iss. 5, 2002-11 ,pp. : 841-845

Elsevier

Access to resources Recommend Favorite

Comparison of nuclear morphometric results between needle biopsy and surgical specimens from patients with prostate cancer

By Zhang Y.H.   Kanamaru H.   Oyama N.   Miwa Y.   Suzuki Y.   Akino H.   Noriki S.   Okada K.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 763-766

Elsevier

Access to resources Recommend Favorite

Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

By D'Amico A.V.   Whittington R.   Malkowicz S.B.   Wu Y.H.   Chen M.-H.   Art M.   Tomaszewski J.E.   Wein A.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 572-577

Elsevier

Access to resources Recommend Favorite

Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer: is volume-Weighted mean nuclear volume superior to other morphometric parameters?

By Zhang Y.H.   Kanamaru H.   Oyama N.   Miwa Y.   Suzuki Y.   Akino H.   Noriki S.   Okada K.  

Urology, Vol. 55, Iss. 3, 2000-03 ,pp. : 377-381

Elsevier

Access to resources Recommend Favorite